Vivos Inc (RDGL) Financial Statements (2026 and earlier)

Company Profile

Business Address 719 JADWIN AVENUE
RICHLAND, WA 99352
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2026
MRQ
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,5592,2131,5921,7061,606904
Cash and cash equivalent1,5592,2131,5921,7061,606904
Receivables2210711  
Inventory, net of allowances, customer advances and progress billings57     
Inventory57     
Prepaid expense131111262834
Total current assets:1,6512,2331,6101,7431,634938
Noncurrent Assets
Operating lease, right-of-use asset111     
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization103  2  
Intangible asset, including goodwill, after accumulated amortization     1414
Intangible asset, excluding goodwill, after accumulated amortization     1414
Other noncurrent assets3     
Other undisclosed noncurrent assets    (2)(14)(14)
Total noncurrent assets:217     
TOTAL ASSETS:1,8682,2331,6101,7431,634938
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:928624582167362
Interest and dividends payable 101
Employee-related liabilities 66
Other undisclosed accounts payable and accrued liabilities928624582167195
Debt      107
Due to related parties  269
Other undisclosed current liabilities25    167
Total current liabilities:1188624582167906
Noncurrent Liabilities
Liabilities, other than long-term debt89     
Operating lease, liability89     
Total noncurrent liabilities:89     
Total liabilities:2078624582167906
Equity
Equity, attributable to parent, including:1,6612,1471,3651,6611,46732
Common stock455441388363344292
Common stock, share subscribed but unissued, subscriptions receivable  (2)    
Additional paid in capital80,28377,71973,79171,21868,57364,552
Accumulated deficit(88,427)(85,361)(82,451)(79,556)(77,086)(74,558)
Other undisclosed equity, attributable to parent9,3509,3509,6379,6379,6379,746
Total equity:1,6612,1471,3651,6611,46732
TOTAL LIABILITIES AND EQUITY:1,8682,2331,6101,7431,634938

Income Statement (P&L) ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues6852036157
Cost of revenue
(Cost of Product and Service Sold)
(128)(31)(26)(29)(12)(6)
Other undisclosed gross profit  23    
Gross profit:(60)(3)(6)831
Operating expenses(3,105)(2,601)(2,787)(2,525)(2,505)(674)
Operating loss:(3,165)(2,604)(2,793)(2,518)(2,502)(673)
Nonoperating income (expense)99(306)(102)48(26)(284)
Investment income, nonoperating (381)(151)   
Interest and debt expense    48(137)(287)
Other undisclosed income from continuing operations before equity method investments, income taxes      287
Loss from continuing operations before equity method investments, income taxes:(3,066)(2,910)(2,895)(2,423)(2,665)(957)
Other undisclosed income (loss) from continuing operations before income taxes    (48)137 
Loss from continuing operations:(3,066)(2,910)(2,895)(2,470)(2,528)(957)
Loss before gain (loss) on sale of properties:(2,528)(957)
Net loss available to common stockholders, diluted:(3,066)(2,910)(2,895)(2,470)(2,528)(957)

Comprehensive Income ($ in thousands)

3/31/2026
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net loss:(3,066)(2,910)(2,895)(2,470)(2,528)(957)
Comprehensive loss, net of tax, attributable to parent:(3,066)(2,910)(2,895)(2,470)(2,528)(957)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: